Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 639083, 10 pages
http://dx.doi.org/10.1155/2013/639083
Research Article

Coniferyl Ferulate, a Strong Inhibitor of Glutathione S-Transferase Isolated from Radix Angelicae sinensis, Reverses Multidrug Resistance and Downregulates P-Glycoprotein

1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China
2New Drug Research and Development Centre of North China Pharmaceutical Group Corporation, Hebei 050015, China
3College of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China
4College of Pharmaceutical Science, Hebei University, Baoding, Hebei 071002, China
5China Academy of Chinese Medical Sciences, Beijing 100700, China

Received 16 May 2013; Accepted 24 June 2013

Academic Editor: Shun-Fa Yang

Copyright © 2013 Chang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sun, X. Xu, Q. Lu, Q. Pan, and X. Hu, “Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1,” Cancer Letters, vol. 246, no. 1-2, pp. 300–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. W.-F. Fong, C. Wang, G.-Y. Zhu, C.-H. Leung, M.-S. Yang, and H.-Y. Cheung, “Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract,” Phytomedicine, vol. 14, no. 2-3, pp. 160–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. B. Longley and P. G. Johnston, “Molecular mechanisms of drug resistance,” Journal of Pathology, vol. 205, no. 2, pp. 275–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Townsend and K. D. Tew, “The role of glutathione-S-transferase in anti-cancer drug resistance,” Oncogene, vol. 22, no. 47, pp. 7369–7375, 2003. View at Google Scholar · View at Scopus
  5. M. J. Ruiz-Gómez, A. Souviron, M. Martínez-Morillo, and L. Gil, “P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine,” Journal of Physiology and Biochemistry, vol. 56, no. 4, pp. 307–312, 2000. View at Google Scholar · View at Scopus
  6. C. J. Henderson, K. J. Ritchie, A. McLaren, P. Chakravarty, and C. R. Wolf, “Increased skin papilloma formation in mice lacking glutathione transferase GSTP,” Cancer Research, vol. 71, no. 22, pp. 7048–7060, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Schultz, S. Dutta, and K. D. Tew, “Inhibitors of glutathione S-transferases as therapeutic agents,” Advanced Drug Delivery Reviews, vol. 26, no. 2-3, pp. 91–104, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Zhao, T. Yu, R. Wang, X. Wang, and Y. Jing, “Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition,” Bioorganic and Medicinal Chemistry, vol. 13, no. 12, pp. 4056–4062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. D. Tew, A. Monks, L. Barone et al., “Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program,” Molecular Pharmacology, vol. 50, no. 1, pp. 149–159, 1996. View at Google Scholar · View at Scopus
  10. M. Volm, M. Kastel, J. Mattern, and T. Efferth, “Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto- oncogene products in renal cell carcinomas,” Cancer, vol. 71, no. 12, pp. 3981–3987, 1993. View at Google Scholar · View at Scopus
  11. R. Pérez-Tomás, “Multidrug resistance: retrospect and prospects in anti-cancer drug treatment,” Current Medicinal Chemistry, vol. 13, no. 16, pp. 1859–1876, 2006. View at Google Scholar
  12. D. Xu, Q. Lu, and X. Hu, “Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol,” Cancer Letters, vol. 243, no. 2, pp. 274–280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Utz, V. Gekeler, W. Ise et al., “Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines,” Anticancer Research, vol. 16, no. 1, pp. 289–296, 1996. View at Google Scholar · View at Scopus
  14. V. Adler, Z. Yin, S. Y. Fuchs et al., “Regulation of JNK signaling by GSTp,” EMBO Journal, vol. 18, no. 5, pp. 1321–1334, 1999. View at Google Scholar · View at Scopus
  15. A. Sau, F. Pellizzari Tregno, F. Valentino, G. Federici, and A. M. Caccuri, “Glutathione transferases and development of new principles to overcome drug resistance,” Archives of Biochemistry and Biophysics, vol. 500, no. 2, pp. 116–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Zhao, T. Yu, R. Wang, X. Wang, and Y. Jing, “Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1-1 activity inhibition,” Bioorganic and Medicinal Chemistry, vol. 13, no. 12, pp. 4056–4062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Hall, C. N. Robson, I. D. Hickson, A. L. Harris, S. J. Proctor, and A. R. Cattan, “Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line,” Cancer Research, vol. 49, no. 22, pp. 6265–6268, 1989. View at Google Scholar · View at Scopus
  18. J. M. Ford, W. N. Hait, S. A. Matlin, and C. C. Benz, “Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers,” Cancer Letters, vol. 56, no. 1, pp. 85–94, 1991. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Lage, “An overview of cancer multidrug resistance: a still unsolved problem,” Cellular and Molecular Life Sciences, vol. 65, no. 20, pp. 3145–3167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Mukanganyama, M. Widersten, Y. S. Naik, B. Mannervik, and J. A. Hasler, “Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance,” International Journal of Cancer, vol. 97, no. 5, pp. 700–705, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Gyamfi, I. I. Ohtani, E. Shinno, and Y. Aniya, “Inhibition of glutathione S-transferases by thonningianin A, isolated from the African medicinal herb, Thonningia sanguinea, in vitro,” Food and Chemical Toxicology, vol. 42, no. 9, pp. 1401–1408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Van Zanden, O. B. Hamman, M. L. P. S. Van Iersel et al., “Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin,” Chemico-Biological Interactions, vol. 145, no. 2, pp. 139–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Duvoix, F. Morceau, S. Delhalle et al., “Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1475–1483, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Das, S. V. Singh, H. Mukhtar, and Y. C. Awasthi, “Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols,” Biochemical and Biophysical Research Communications, vol. 141, no. 3, pp. 1170–1176, 1986. View at Google Scholar · View at Scopus
  25. M. A. Metwally, R. M. King, and H. Robinson, “An acetylenic epoxide and a ferulate from Coreopsis longula,” Phytochemistry, vol. 24, no. 1, pp. 182–183, 1985. View at Google Scholar · View at Scopus
  26. F. Huang, S. Li, X. Lu, A. Liu, G. Du, and G. Shi, “Two glutathione S-transferase inhibitors from Radix Angelicae sinensis,” Phytotherapy Research, vol. 25, no. 2, pp. 284–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. X.-H. Wang, D.-Z. Jia, Y.-J. Liang et al., “Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway,” Cancer Letters, vol. 249, no. 2, pp. 256–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Szakács, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman, “Targeting multidrug resistance in cancer,” Nature Reviews Drug Discovery, vol. 5, no. 3, pp. 219–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Lehne, “P-glycoprotein as a drug target in the treatment of multidrug resistant cancer,” Current Drug Targets, vol. 1, no. 1, pp. 85–99, 2000. View at Google Scholar · View at Scopus
  30. A. Palmeira, F. Rodrigues, E. Sousa, M. Pinto, M. H. Vasconcelos, and M. X. Fernandes, “New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors,” Chemical Biology and Drug Design, vol. 78, no. 1, pp. 57–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. A. A. M. Dirven, B. Van Ommen, and P. J. Van Bladeren, “Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases,” Chemical Research in Toxicology, vol. 9, no. 2, pp. 351–360, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Nakajima, T. Takayama, K. Miyanishi et al., “Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-π-specific inhibitor O1-hexadecyl-γ-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 861–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Volm, M. Kastel, J. Mattern, and T. Efferth, “Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto- oncogene products in renal cell carcinomas,” Cancer, vol. 71, no. 12, pp. 3981–3987, 1993. View at Google Scholar · View at Scopus
  34. J. Liu, H. Chen, D. S. Miller et al., “Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic,” Molecular Pharmacology, vol. 60, no. 2, pp. 302–309, 2001. View at Google Scholar · View at Scopus
  35. G.-H. Lu, K. Chan, Y.-Z. Liang et al., “Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related umbelliferae herbs,” Journal of Chromatography A, vol. 1073, no. 1-2, pp. 383–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-C. Hsieh, W.-C. Lin, M.-R. Lee et al., “Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice,” Immunopharmacology and Immunotoxicology, vol. 25, no. 2, pp. 259–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. C. C. Quan, J. Lee, W. Jin et al., “Cytotoxic constituents from Angelicae sinensis Radix,” Archives of Pharmacal Research, vol. 30, no. 5, pp. 565–569, 2007. View at Google Scholar · View at Scopus
  38. T. P. Mulder, W. H. Peters, T. Wobbes, B. J. Witteman, and J. B. Jansen, “Measurement of glutathione S-transferase P1-1 in plasma: pitfalls and significance of screening and follow-up of patients with gastrointestinal carcinoma,” Cancer, vol. 80, no. 5, pp. 873–880, 1997. View at Google Scholar
  39. A. J. Oakley, M. Lo Bello, A. P. Mazzetti, G. Federici, and M. W. Parker, “The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes,” FEBS Letters, vol. 419, no. 1, pp. 32–36, 1997. View at Publisher · View at Google Scholar · View at Scopus